Overview of Diagnosis and Management of Metastatic Disease to Bone

被引:1
|
作者
Yu, Hsiang-Hsuan Michael [1 ]
Tsai, Ya-Yu [2 ]
Hoffe, Sarah E. [1 ]
机构
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL 33612 USA
[2] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol & Genet, Tampa, FL 33612 USA
关键词
POSITRON-EMISSION-TOMOGRAPHY; RANDOMIZED-TRIAL; 8; GY; ZOLEDRONIC ACID; CANCER-PATIENTS; BREAST-CANCER; SKELETAL COMPLICATIONS; RADIOTHERAPY TRIALS; MULTIPLE FRACTIONS; DOUBLE-BLIND;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Bone metastases occur frequently in patients with advanced cancer and are a serious complication of cancer. The decision to treat is often individualized, based on each patient's clinical presentation, life expectancy, and quality of life. Methods: We reviewed the current literature pertaining to management of metastatic disease to bone, and the medical, radiotherapeutic, and surgical treatment options for management of bone metastasis are discussed. Results: Current management of skeletal metastasis includes analgesia, systemic therapy, radiation therapy, and surgery. We propose treatment algorithms for management of vertebral and nonvertebral bone metastases and suggest individualized interventions based on clinical presentation. Conclusions: Management of bone metastases is complex and requires a multidisciplinary approach. The goal of treatment is often palliative, and intervention and treatment regimens should be individualized based on the specific clinical presentation of each patient.
引用
收藏
页码:84 / 91
页数:8
相关论文
共 50 条
  • [21] A multicenter, retrospective epidemiologic survey of the clinical features and management of bone metastatic disease in China
    Yang, Yunpeng
    Ma, Yuxiang
    Sheng, Jin
    Huang, Yan
    Zhao, Yuanyuan
    Fang, Wenfeng
    Hong, Shaodong
    Tian, Ying
    Xue, Cong
    Zhang, Li
    CHINESE JOURNAL OF CANCER, 2016, 35
  • [22] A scoping review on the surgical management of metastatic bone disease of the extremities
    Kendal, Joseph K.
    Abbott, Annalise
    Kooner, Sahil
    Johal, Herman
    Puloski, Shannon K. T.
    Monument, Michael J.
    BMC MUSCULOSKELETAL DISORDERS, 2018, 19
  • [23] Current Controversies in the Management of Myeloma Bone Disease
    Silbermann, Rebecca
    Roodman, Garson David
    JOURNAL OF CELLULAR PHYSIOLOGY, 2016, 231 (11) : 2374 - 2379
  • [24] Therapeutic Options in the Management of Myeloma Bone Disease
    Berenson, James R.
    SEMINARS IN ONCOLOGY, 2010, 37 (03) : S20 - S29
  • [25] The use of zoledronic acid in the management of metastatic bone disease and hypercalcaemia
    Neville-Webbe, HL
    Coleman, RE
    PALLIATIVE MEDICINE, 2003, 17 (06) : 539 - 553
  • [26] Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid
    Vadhan-Raj, S.
    von Moos, R.
    Fallowfield, L. J.
    Patrick, D. L.
    Goldwasser, F.
    Cleeland, C. S.
    Henry, D. H.
    Novello, S.
    Hungria, V.
    Qian, Y.
    Feng, A.
    Yeh, H.
    Chung, K.
    ANNALS OF ONCOLOGY, 2012, 23 (12) : 3045 - 3051
  • [27] Management of bone metastases
    Tamas, Nagykalnai
    Laszlo, Landherr
    ORVOSI HETILAP, 2014, 155 (06) : 217 - 225
  • [28] Synergistic effect of bisphosphonate and docetaxel on the growth of bone metastasis in an animal model of established metastatic bone disease
    van Beek, E. R.
    Lowik, C. W. G. M.
    van Wijngaarden, J.
    Ebetino, F. H.
    Papapoulos, S. E.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 118 (02) : 307 - 313
  • [29] Management of Metastatic Disease in Long Bones
    Auran, Richard L.
    Martin, John R.
    Duran, Michael D.
    de Comas, Amalia M.
    Jacofsky, David J.
    JOURNAL OF ORTHOPAEDIC TRAUMA, 2022, 36 (09) : 481 - 488
  • [30] HIF targets in bone remodeling and metastatic disease
    Johnson, Rachelle W.
    Schipani, Ernestina
    Giaccia, Amato J.
    PHARMACOLOGY & THERAPEUTICS, 2015, 150 : 169 - 177